0000899140-24-000705.txt : 20240710 0000899140-24-000705.hdr.sgml : 20240710 20240710111145 ACCESSION NUMBER: 0000899140-24-000705 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240623 FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DONG-A ST CO., LTD CENTRAL INDEX KEY: 0001799260 ORGANIZATION NAME: STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 241109117 BUSINESS ADDRESS: STREET 1: 64, CHEONHO-DAERO STREET 2: DONGDAEMUN-GU CITY: SEOUL STATE: M5 ZIP: 02587 BUSINESS PHONE: 82-2-920-8184 MAIL ADDRESS: STREET 1: 64, CHEONHO-DAERO STREET 2: DONGDAEMUN-GU CITY: SEOUL STATE: M5 ZIP: 02587 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 545 CONCORD AVENUE STREET 2: SUITE 210 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4/A 1 form4.xml X0508 4/A 2024-06-23 2024-06-25 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001799260 DONG-A ST CO., LTD 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 KOREA, REPUBLIC OF true false Common Stock 2024-06-23 4 P 0 2544530 3.93 A 5348229 D This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share. Dong-A St Co., Ltd.; By: /s/ Min Young Kim, Chief Executive Officer 2024-07-10